Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron, Bruker Daltonics, Gary Blackburn, Nicholas Cozzarelli, Nicholas Ventresca


New Products

Thermo Electron announced last week the expansion of its HeavyPeptide AQUA product line. The HeavyPeptide AQUA kits can now be prepared with covalent modifications, such as phosphorylation, which are chemically identical to naturally occurring post-translational modifications.

Phosphorylation modification is now also available on Thermo's HeavyPeptide BASIC platform for high-throughput, pre-quantitative screening, and relative quantification.

Bruker Daltonics launched this week its Clinprot Forum — an online forum moderated by Bruker application scientists that is available for all Bruker Daltonics customers at

The discussion forum covers various aspects of clinical proteomics, such as biofluid profiling and validation, biomarker identification, the MALDI Molecular Imager, and the MALDI BioTyper for microorganism identification. It is designed to facilitate efficient information exchange and to stimulate the formation of research collaborations between different laboratories, Bruker said. Discussion threads include topics like sample preparation, standardization, biomarker identification, and bioinformatics methods.


Movers & Shakers

Gary Blackburn has become president and chief executive officer of Ohmx, the Evanston, Ill.-based protein biosensor company said on Monday. Most recently, he was director of research and technology at Motorola Clinical Micro Sensors.

Nicholas Cozzarelli, editor in chief of PNAS and a professor of molecular and cell biology at the University of California, Berkeley, died on March 19 from complications of treatment for Burkitt's lymphoma. He was 67. Cozzarelli received an undergraduate degree in biology from Princeton University and a PhD in biochemistry from Harvard Medical School.

Nicholas Ventresca has become corporate senior vice president of information technology as well as chief information officer of Charles River Laboratories, the company said last week. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.